Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.33

+3.6%

3:43 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (10470)	10/30/1997 11:00:00 PM
From: Henry Niman	Read Replies (1) of 32384

Stan, When I first started thinking about SRGN as an acquisition candidate, I wasn't sure what LGND saw. I've always assumed that the GLYC acquisition was more for the cash than the technology. SRGN doesn't seem to have much cash, but the technology seems to be a better fit. I haven't looked at them that hard, but they do seem to have several alliances and a few advanced trials, but it seems that they have a market cap of only something like $10 million. Am I missing some classes of shares that would make their market cap much higher, or is this what happens when a Biotech runs out of cash?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next